These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23967071)
1. An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. Lo WY; Chang NW PLoS One; 2013; 8(8):e70198. PubMed ID: 23967071 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of indirubin-3'-monoxime against human osteosarcoma. Zhang Y; Song L; Li J; Zhang Y; Lu X; Zhang B IUBMB Life; 2019 Oct; 71(10):1465-1474. PubMed ID: 31050877 [TBL] [Abstract][Full Text] [Related]
3. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells. Shi J; Shen HM Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873 [TBL] [Abstract][Full Text] [Related]
4. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155 [TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells. Perabo FG; Landwehrs G; Frössler C; Schmidt DH; Mueller SC Urol Oncol; 2011; 29(6):815-20. PubMed ID: 19945313 [TBL] [Abstract][Full Text] [Related]
6. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation. Al-Sharif I; Remmal A; Aboussekhra A BMC Cancer; 2013 Dec; 13():600. PubMed ID: 24330704 [TBL] [Abstract][Full Text] [Related]
7. Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells. Lee MY; Liu YW; Chen MH; Wu JY; Ho HY; Wang QF; Chuang JJ Oncol Rep; 2013 May; 29(5):2072-8. PubMed ID: 23468088 [TBL] [Abstract][Full Text] [Related]
8. Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer. Dera AA; Rajagopalan P; Al Fayi M; Ahmed I; Chandramoorthy HC Arch Pharm Res; 2020 Jun; 43(6):655-665. PubMed ID: 32588331 [TBL] [Abstract][Full Text] [Related]
9. Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca Dilshara MG; Neelaka Molagoda IM; Prasad Tharanga Jayasooriya RG; Choi YH; Park C; Kim GY Arch Biochem Biophys; 2021 Feb; 698():108723. PubMed ID: 33321111 [TBL] [Abstract][Full Text] [Related]
10. Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells. Kim JK; Park GM Inflamm Res; 2012 Apr; 61(4):319-25. PubMed ID: 22187016 [TBL] [Abstract][Full Text] [Related]
11. Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis. Kim JK; Shin EK; Kang YH; Park JH J Cell Biochem; 2011 May; 112(5):1384-91. PubMed ID: 21337385 [TBL] [Abstract][Full Text] [Related]
12. Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells. Rajagopalan P; Dera A; Abdalsamad MR; C Chandramoorthy H J Food Biochem; 2019 Jul; 43(7):e12861. PubMed ID: 31353710 [TBL] [Abstract][Full Text] [Related]
13. 5'-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells. Kim SA; Kim SW; Chang S; Yoon JH; Ahn SG Cancer Lett; 2009 Feb; 274(1):72-7. PubMed ID: 18926623 [TBL] [Abstract][Full Text] [Related]
14. Indirubin-3'-oxime induces mitochondrial dysfunction and triggers growth inhibition and cell cycle arrest in human neuroblastoma cells. Liao XM; Leung KN Oncol Rep; 2013 Jan; 29(1):371-9. PubMed ID: 23117445 [TBL] [Abstract][Full Text] [Related]
15. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378 [TBL] [Abstract][Full Text] [Related]
17. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Huang KF; Zhang GD; Huang YQ; Diao Y Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy. Gao W; Lu C; Chen L; Keohavong P J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636 [TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative--Enhancement of both extrinsic and intrinsic apoptosis pathways. Berger A; Quast SA; Plötz M; Hein M; Kunz M; Langer P; Eberle J Biochem Pharmacol; 2011 Jan; 81(1):71-81. PubMed ID: 20858462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]